celulas derivadas de placenta a termino

Upload: luis-carlos-quinto-cuzcano

Post on 17-Feb-2018

215 views

Category:

Documents


0 download

TRANSCRIPT

  • 7/23/2019 Celulas Derivadas de Placenta a Termino

    1/11

    Revista de HematologaVolumen 12, nm. 4, octubre-diciembre 2011276

    Artculo de revisin

    Rev Hematol Mex 2011;12(4):276-286

    Utilidad teraputica potencial de las clulas madre de la membranaamniticaCarmen L Insausti,* Miguel Blanquer,* Mara J Majado,* Alfredo Insausti,** Jos M Moraleda*,***

    RESUMEN

    Desde los primeros estudios de clulas madre obtenidas de la membrana amnitica se ha avanzado mucho en el conocimiento de las

    caractersticas de estas clulas, sus mtodos de obtencin y procesamiento, as como de su potencialidad. Numerosos ensayos preclnicos

    sugieren que las clulas madre de la membrana amnitica podran ser tiles en la regeneracin de una serie de alteraciones tisulares.

    estrecha colaboracin entre la investigacin bsica y los clnicos para que la terapia con clulas se haga realidad en la prctica diaria.

    Palabras clave: membrana amnitica, clulas madre, clulas de la membrana amnitica, clulas epiteliales, clulas mesenquimales,terapia celular.

    ABSTRACT

    handling methods and potential of these cells. A lot of preclinical evidence suggests that human amniotic derived cells may be useful for

    of amniotic derived cells are due to differentiation of the transplanted cells themselves or to paracrine actions on the surrounding host tissue

    clinical reality, it is fundamental a close collaboration between basic scientists and clinicians.

    Key words:Amnion, amniotic membrane, stem cell, amniotic epithelial stem cell, amniotic mesenchymal stem cell, Cell therapy.

    * Servicio de Hematologa y Hemoterapia. Unidad de TerapiaCelular. Hospital Universitario Virgen de la Arrixaca.

    ** Servicio de Oftalmologa. Hospital Universitario La Paz, Madrid.*** Universidad de Murcia. Murcia, Madrid.

    Correspondencia: Dra. Carmen L Insausti. Servicio de Hematologa

    y Hemoterapia, Unidad de Terapia Celular. Hospital UniversitarioVirgen de la Arrixaca. Ctra. Madrid-Cartagena. El Palmar 30120,Murcia. Correo electrnico: [email protected]: octubre 2011. Aceptado: noviembre 2011.

    Este artculo debe citarse como: Insausti CL, Blanquer M, MajadoMJ, Insausti A, Moraleda JM. Utilidad teraputica potencial delas clulas madre de la membrana amnitica. Rev Hematol Mex2011;12(4):276-286.

    L

    - 1,2

    2 1-4

    acelular,

    -

  • 7/23/2019 Celulas Derivadas de Placenta a Termino

    2/11

    277Revista de HematologaVolumen 12, nm. 4, octubre-diciembre 2011

    Utilidad teraputica potencial de las clulas madre de la membrana amnitica

    fuera de sta se encuentra una capa dispersa de clulas

    3,4

    - human Amniotic Epithelial cells, - -

    human Amniotic MesenchymalStem or Stromal cells -

    - -

    invitro

    Tumor Necrosis Factor) Transforming factor) (Epidermal Growth Factor Hepatic

    growth factor Keratinocytesgrowth factor -

    Usos de las hAEC y hAMSC en modelos animales

    - -

    Brain derived netrophic factor y NT-3:eurotrophin-3) 28

    -

  • 7/23/2019 Celulas Derivadas de Placenta a Termino

    3/11

    Revista de HematologaVolumen 12, nm. 4, octubre-diciembre 2011278

    L Insausti C y col.

    Cuadro 1.Trasplante de HAEC o HAMSC en modelos animales de enfermedades

    Enfermedad Animal Evolucin Referencias

    Enfermedad de Parkinson

    Contusin del cordn medular

    Obstruccin arterial cerebral media

    Tejido heptico

    Fibrosis heptica

    Infarto cardiaco

    Diabetes

    Fibrosis pulmonar

    Tejido cartilaginoso

    Enfermedades del odo

    Pared abdominal

    Isquemia de extremidades

    Rata

    Ratn

    Rata

    Mono

    Rata

    Rata

    Ratn

    Conejo

    Ratn

    Rata

    Ratn

    Ratn

    Ratn

    Rata

    Cobayo

    Rata

    Ratn

    Supervivencia celular. Sntesis y secrecin de catecolaminas y factores

    -

    paminrgicas.

    Efecto neuroprotector y neurognico.

    Mejora clnica. Expresin de marcadores neurales

    Integracin celular sin reaccin inmunitaria

    Supervivencia celular. Expresin de marcadores neuronales. Disminucin

    del rea infartada. Mejora clnica

    Integracin en tejido heptico. Expresin de marcadores hepticos.

    Integracin heptica. Expresin de receptores.

    Supervivencia celular. Expresin de marcadores cardiacos. Mejora de

    la funcin cardiaca.Correccin de hiperglucemia. Integracin celular en el hgado y el pncreas

    Produccin de protenas surfactantes A, B, C y D.

    Expresin de genes, receptores, colgeno tipo II y aggrecan

    Localizacin en la regin supra-limbal, regin supra-espiral en la scala

    vestibuliy en la regin subcentral del ligamento espiral en la scala timpani.

    Supervivencia durante 3 semanas. Expresin de marcadores.

    Integracin celular. Mejora de cicatrizacin. Reduccin de la incidencia

    y tamao de hernias incisionales.

    27,28,

    29

    30

    31

    32

    33

    5,35,37,39

    36

    40

    41,42

    44

    45,46

    18

    47

    48

    49

    - - 3,4-Dihydroxyphenylaceticacid: Homovanilic acid) en el striatum del

    -

    -31

    32 -

    33tras el tras-

  • 7/23/2019 Celulas Derivadas de Placenta a Termino

    4/11

    279Revista de HematologaVolumen 12, nm. 4, octubre-diciembre 2011

    Utilidad teraputica potencial de las clulas madre de la membrana amnitica

    34 fuente de clulas para la terapia celular en ictus, una

    -

    -

    -

    36 Low density lipoprotein receptor

    - -

    -

    38 - -

    present tripsina humana.

    en

    4), trasplan-

    41

  • 7/23/2019 Celulas Derivadas de Placenta a Termino

    5/11

    Revista de HematologaVolumen 12, nm. 4, octubre-diciembre 2011280

    L Insausti C y col.

    -

    2

    -

    42

    43 -

    - -

    44 -

    2

    - - -

    -

    46

    18

    - - en la matriz pericelular.

  • 7/23/2019 Celulas Derivadas de Placenta a Termino

    6/11

    281Revista de HematologaVolumen 12, nm. 4, octubre-diciembre 2011

    Utilidad teraputica potencial de las clulas madre de la membrana amnitica

    -

    in vitro - - invivo - lascala vestibuli espiral en lascala timpani,

    48 - Amniotic multipotentcells -

    -

    - -

    in vivo de 18,33,41 -

    -

    -

    enfermedades.

    - -

  • 7/23/2019 Celulas Derivadas de Placenta a Termino

    7/11

    Revista de HematologaVolumen 12, nm. 4, octubre-diciembre 2011282

    L Insausti C y col.

    -

    -

    61

    -

    -

    1. -

    6

    -

    -

    -

    - 6

    - pacientes.

    - 6 6

  • 7/23/2019 Celulas Derivadas de Placenta a Termino

    8/11

    283Revista de HematologaVolumen 12, nm. 4, octubre-diciembre 2011

    Utilidad teraputica potencial de las clulas madre de la membrana amnitica

    -

    Cuadro 2.Publicaciones recientes acerca de la indicacin clnica de la membrana amnitica

    Aos Ttulos Referencias

    2000

    2001

    2003

    2004

    2005

    2006

    2007

    2008

    2009

    2010

    Reconstitution of damaged corneas by transplantation of autologous limbal epithelial cells

    Amniotic membrane graft in ocular surface disease. Prospective study with 31 cases.

    Successful reconstruction of damaged ocular outer surface in humans using limbal and conjuctival stem cell

    culture methods.

    The Amniotic membrane in ophthalmology

    Amniotic membrane use in ophthalmology

    Amniotic membrane transplantation for ocular surface reconstruction.

    Ultrastructural analysis of in vivo expanded corneal epithelium on amniotic membrane

    Amniotic membrane transplantation for treatment of symblepharon in a patient with recessive dystrophic epi-

    dermolysis bullosa.Amniotic Membrane transplantation in palliative treatment of bullous keratopathy

    Clinical outcome of autologous cultivated limbal epithelium transplantation

    Amniotic Membrane Transplantation

    Use of amniotic membrane graft and corneal transplantation in a patient with bilateral keratomalacia induced

    by uncontrolled phenylketonuria

    Use of amniotic membrane transplantation in the treatment of venous leg ulcers.

    Amnia for intractable skin ulcers with recessive dystrophic epidermolysis bullosa: report of three cases.

    Amniotic membrane transplantation for the management of corneal epithelial defects: an in vivo confocal mi-

    croscopic study.

    Manufacturing of human placenta-derived mesenchymal stem cells for clinical trials

    Amniotic membrane transplantation in the treatment of persistent epithelial defect on the corneal graft.Use of amniotic membrane transplantation in isolated conjunctival Bowen disease: a case report

    Dried irradiated human amniotic membrane as a biological dressing for facial burns--a 7-year case series

    Amniotic membrane induces epithelialization in massive posttraumatic wounds.

    62

    68

    69

    55

    56

    64

    65

    63

    59

    70

    57

    60

    71

    72

    66

    75

    6761

    73

    74

    experiencias en pacientes.

    CONCLUSIN

    - -

  • 7/23/2019 Celulas Derivadas de Placenta a Termino

    9/11

    Revista de HematologaVolumen 12, nm. 4, octubre-diciembre 2011284

    L Insausti C y col.

    - Good Manufacturing Practice -

    Agradecimientos

    -

    REFERENCIAS

    1. Bourne G. The Foetal Membranes. A Review of the Anatomy

    of Normal Amnion and Chorion and Some Aspects of Their

    Function. Postgrad Med J 1962;38:193-201.

    2. Benirschke K., Kaufman P. Anatomy and Pathology of the

    placental membranes. In: Pathology of the Human Placenta.

    4th

    ed. New York: Springer, 2000;281-334.3. Niknejad H, Peirovi H, Jorjani M, Ahmadiani A, et al. Pro-

    perties of the amniotic membrane for potential use in tissue

    engineering. European Cells and materials 2008; 15:88-99.

    4. Dobreva MP, Pereira PM, Deprest J, Zwijsen A. On the ori-

    gin of amniotic stem cells: of mice and men. Int J Dev Biol

    2010;54:761-777.

    5. Miki T, Lehmann T, Cai H, Stolz D, Strom S. Stem cell charac-

    teristics of amniotic epithelial cells. Stem Cells 2005;23:1549-

    1559.

    6. Miki T, Strom SC. Amnion derived pluripotent-multipotent stem

    cells. Stem Cell Rev 2006;2:133-142.

    7. Ilancheran S, Michalska A, Peh G, Wallace EM, et al. Stem

    cell derived from human fetal membranes display multilineage

    differentiation potential. Biol Reprod 2007;77(3):577-588.

    8. Insausti CL, Blanquer M, Bleda P, Iniesta P, et al. The amnio-

    tic membrane as a source of stem cells. Histol Histopathol

    2010;25:91-98.

    9. Takashima S, Ise H, Zhao P, Akaike T, Nikaido T. Human am-

    niotic epithelial cells possess hepatocyte-like characteristics

    and functions. Cell Struct Funct 2004;29:73-83.

    10. Niknejad H, Peirovi H, Ahmadiani A, Ghanavi J, Jorjani M. Di-

    in vitro from human amniotic epithelial cells. European Cells

    and Materials 2010;19:22-29.

    11. Bilic G, Zeisberger SM, Mallik AS, Zimmermann R, Zisch AH.

    Comparative Characterization of Cultured Human Term Am-

    nion Epithelial and Mesenchymal Stromal Cells for Application

    in Cell Therapy. Cell Transplantation 2008;17:955-968.

    12. Parolini O, Soncini M. Human Placenta: a source of progenitor/

    stem cells? J Reproduktionsmed Endokrinol 2006;3:117-126.

    13. Portmann-Lanz CB, Schoeberlein A, Huber A, Sager R, et al.

    Placental mesenchymal stem cells as potential autologous

    graft for pre and perinatal neuroregeneration. Am J Obstet

    Gynecol 2006;194:664-673.

    14. Parolini O, Alviano F, Bergwerf I, Boraschi D, et al. Toward cell

    therapy using placenta-derived cells: Disease mechanisms,

    cell biology, preclinical studies, and regulatory aspects at the

    round table. Stem cells and development 2010;19:143-154.

    15. Alviano F, Fossati V, Marchionni C, Arpinati M, et al. Term

    amniotic membrane is a high throughput source for multipo-

    tent mesenchymal stem cells with the ability to differentiate

    into endothelial cells in vitro. BMC developmental. Biology

    2007; 7:1-14.

    16. Soncini M, Vertua E, Gibelli L, Zorzi F, et al. Isolation andcharacterization of mesenchymal cells from human fetal mem-

    branes. J Tissue Eng Regen Med 2007; 1:296-305.

    17. Kim J, Mi Kang H, Kim H, Ran Kim M, et al. Ex vivocharac-

    teristics of human amniotic membrane- derived stem cells.

    Cloning and stem cells 2007;9:581-594.

    18. Wei JP, Nawata M, Wakitani S, Kametani K, et al. Human

    amniotic mesenchymal cells differentiate into chondrocytes.

    Cloning and Stem Cells 2009;11:19-25.

    19. Parolini O, Alviano F, Bagnara G, Bilic G, et al. Concise Re-

    view: Isolation and characterization of cells from human term

    placenta: outcome of the First International Workshop on

    Placenta Derived Stem Cells. Stem Cells 2008;26:300-311.

    20. Whittle WL, Gibb W, Challis JRG. Characterization of human

    amnion epithelial and mesenchymal cells: the cellular expres-

    sion, activity and glucocorticoid regulation of prostaglandinoutput. Placenta 2000;21:394-401.

    21. Li H, Niederkorn J, Neelam S, Mayhew E, et al. Immunosu-

    ppressive factors secreted by human amniotic epithelial cells.

    Invest Ophthalmol Vis Sci 2005; 46:900-907.

    22. Koizumi NJ, Inatomi TJ, Sotozono CJ, Fullwood NJ, et al.

    Growth factor mRNA and protein in preserved human amniotic

    membrane. Curr Eye Res 2000;20:173-177.

    23.

    amniotic membrane. Cornea 2000;19:348-352.

    24. Solomon A, Rosenblatt M, Monroy D, Ji Z, et al. Suppression

    of interleukin 1 (alpha) and interleukin 1 (beta) in human limbal

    epithelial cells cultured on the amniotic membrane stromal

    matrix. Br J Ophthalmol 2001;85:444-449.

    25. Houlihan JM, Biro PA, Harper HM. The human amnion is a

    site of MHC class Ib expression: evidence for the expression

    of HLA-E y HLA-G. J Immunol 1995;154:5665-5674.

    26. Magatti M, de Munari S, Vertua E, Nassuato C, et al. Amniotic

    mesenchymal tissue cell inhibit dendritic cell differentiation of

    peripheral blood and amnion resident monocytes. Cell Trans-

    plant 2009;18:899-914.

    27. Kakishita K, Elwan MA, Nakao N, Itakura T, Sakurawaga N.

    Human Amniotic epithelial cells produce dopamine and survive

    after implantation into the striatum of a rat model of Parkinsons

  • 7/23/2019 Celulas Derivadas de Placenta a Termino

    10/11

    285Revista de HematologaVolumen 12, nm. 4, octubre-diciembre 2011

    Utilidad teraputica potencial de las clulas madre de la membrana amnitica

    disease: a potential source of donor for transplantation therapy.

    Exp Neurol 2000;165:27-34.

    28. Kakishita K, Nakao N, Sakurawaga N, Itakura T. Implantation

    of human amniotic epithelial cells prevents the degeneration

    of nigral dopamine neurons in rats with 6-hydroxydopamine

    lesions. Brain Res 2003;980:48-56.

    29. Kong XY, Cai Z, Pan L, Zhang L, et al. Transplantation of hu-

    man amniotic cells exerts neuroprotection in MPTP-induced

    Parkinson disease mice. Brain Res 2008; 1205:108-115.

    30. Yang X, Xue S, Dong W, Kong Y. Therapeutic effect of hu-

    man amniotic epithelial cell transplantation into the lateral

    ventricle of hemiparkinsonian rats. Chinese Medical Journal

    2009;122:2449-2454.

    31. Sankar V, Muthusamy R. Role of human amniotic epithelial

    cell transplantation in spinal cord injury repair research. Neu-

    roscience 2003;118:1-17.

    32. Wu ZY, Hui GZ, Lu Y, Wu X, Guo LH. Transplantation of human

    amniotic epithelial cells improves hindlimb function in rats with

    spinal cord injury. Chin Med J (Engl) 2006;119:2101-2107.

    33. Liu Y, Wu J, Huang Q, Hou J, et al. Human Amniotic epithelialcells ameliorate behavioral dysfunction and reduce infarct

    size in the rat middle cerebral artery occlusion model. Shock

    2008;29:603-611.

    34. Yu SJ, Soncini M, Kaneko Y, Hess DC, et al. Amnion a po-

    tent graft source for cell therapy in stroke: Cell Transplant

    2009;18:111-118.

    35. Sakuragawa N, Enosawa S, Ishii T, Thangavel R, et al. Hu-

    man amniotic epithelial cells are promising transgene carriers

    for allogeneic cell transplantation into liver. J Hum Genet

    2000;45:171-176.

    36. Takahashi S, Ohsugi K, Yamamoto T, Shiomi M, Sakuragawa

    N. A novel approach to ex vivo gene therapy for familiar

    hypercholesterolemia using human amniotic epithelial cells

    as transgene carrier. Tohoku J Exp Med 2001;193:279-292.

    37. Takahashi N, Enosawa S, Mitani T, Lu H, et al. Transplantationof amniotic epithelial cells into fetal rat liver by in utero mani-

    pulation. Cell Transplant 2002; 11:443-449.

    38. Takashima S, Ise H, Zhao P, Akaike T, Nikaido T. Human am-

    niotic epithelial cells possess hepatocyte-like characteristics

    and functions. Cell Struct Funct 2004;29:73-83.

    39. Miki T, Marongiu F, Ellis EC, Dorko K, et al. Production of

    hepatocyte-like cells from human amnion. Methods Mol Biol

    2009;481:1-14.

    40. Manuelpillai I, Tchongue J, Lourensz D, Vaghjiani V, et al.

    Transplantation of human amniotic epithelial cells reduce

    4-treated mice. Cell

    Transplantation 2010;19:1157-1168.

    41. Zhao P, Ise H, Hongo M, Ota M, et al. Human amniotic me-

    senchymal cells have some characteristics of cardiomyocytes.

    Transplantation 2005;79:528-535.

    42. Ventura C, Cantoni S, Bianchi F, Lionetti V, et al. Hyaluronan

    mixed esters of butyric and retinoic acid drives cardiac and

    endothelial fate in term placenta human mesenchymal stem

    cells and enhance cardiac repair in infracted rat hearts. J Biol

    Chem 2007;282:14243-14252.

    43. Cargnoni A, Di Marcello M, Campagnol M, Nassuato C, et

    al. Amniotic membrane patching promotes ischemic rat heart

    repair. Cell Transplant 2009;18:1147-1159.

    44. Wei JP, Zhang TS, Kawa S, Aizawa T, et al. Human amnion-iso-

    lated cells normalize blood glucose in streptozotocin-induced

    diabetic mice. Cell Transplant 2003;12:545-552.

    45. Cargnoni A, Gibelli L, Tosini A, Signoroni PB, et al. Trans-

    plantation of allogenic and xenogenic placenta derived cells

    2009;18:405-422

    46. Moodley Y, Ilancheran S, Samuel C, Vaghjiani V, et al. Human

    and augment repair. Am J Respi Crit Care Med 2010;182:643-

    651.

    47. Yuge I, Takumi Y, Koyabu K, Hashimoto S, et al. Transplanted

    human amniotic epithelial express connexin 26 y Na-K-ATPasa

    in the inner ear. Transplantation 2004;77:1452-1454.

    48. Xing L, Franz MG, Marcelo CL, Smith CA, et al. Amnion-derived

    multipotent progenitor cells increase gain of incisional breaking

    strength and decrease incidence and severity of acute wound

    failure. J Burns and Wounds 2007;7:39-52.

    49. -

    tal derived adherent stromal cell (PLX-PAD) in the treatment ofcritical limb ischemia. Cytotherapy 2009;11:427-434.

    50. Davis JW. Skin transplantation with a review of 550 cases at

    the John Hopkins Hospital. Johns Hopkins Med J 1910;15:307-

    396.

    51. Trefold JD, Trelford-Sauer M. The amnion in surgery, past and

    present. Am J Obstet Gynecol 1979;134:833-845.

    52. Ganatra MA. Amniotic membrane in surgery. J Pak Med Assoc

    2003;53:29-32.

    53. De Rotth A. Plastic repair of conjunctival defects with fetal

    membranes. Arch Ophthalmol 1940;23(5):22-525.

    54. Sorby A, Symons HM. Amniotic membrane grafts in caustic

    burns of eye. Br J Ophthalmol 1946;30:337-345.

    55. Dua HS, Gomes JA, King AJ, Maharajan S. The Amniotic

    membrane in ophthalmology. Survey of Ophthalmology

    2004;49:51-77.56. Gomes JA, Roman A, Santos MS, Dua HS. Amniotic membra-

    ne use in ophthalmology. Curr Opin Ophthalmol 2005;16:233-

    240.

    57.

    Amniotic membrane transplantation. Iranian J Ophthalmolol

    Res 2007;2:58-73.

    58. Kim JC y Tseng SC. Transplantation of preserved human

    amniotic membrane for surface reconstruction in severely

    damaged rabbit corneas. Cornea 1995;14: 473-484.

    59. Zemba M, Andrei S, Cucu B, Bratulescu M, et al. Amniotic

    Membrane transplantation in palliative treatment of bullous

    keratopathy. Oftalmologia 2006;50:51-53.

    60. Habot-Wilner Z, Spierer A, Barequet IS, Greenbaum A. Use

    of amniotic membrane graft and corneal transplantation in a

    patient with bilateral keratomalacia induced by uncontrolled

    phenylketonuria. Cornea 2007;26:629-631.

    61. Motolese J, Mazzera L, Frezzotti P, Motolese PA, Motolese

    E. Use of amniotic membrane transplantation in isolated

    conjunctival Bowen disease: a case report. Eur J Ophthalmol

    2010; 20:604-607.

    62. Tsai RJ, Li LM, Chen JK. Reconstruction of damaged corneas

    by transplantation of autologous limbal epithelial cells. N Engl

    J Med 2000;343:86-93.

  • 7/23/2019 Celulas Derivadas de Placenta a Termino

    11/11

    Revista de HematologaVolumen 12, nm. 4, octubre-diciembre 2011286

    L Insausti C y col.

    63. Altan-Yaycioglu R, Akova YA, Oto S. Amniotic membrane

    transplantation for treatment of symblepharon in a patient

    with recessive dystrophic epidermolysis bullosa. Cornea

    2006; 25:971-973.

    64. Fernandes M, Sridhar MS, Sangwan VS, Rao GN. Amniotic

    membrane transplantation for ocular surface reconstruction.

    Cornea 2005;24:643-653.

    65. Ha HS, Song KY, Kim JC. Ultrastructural analysis of in vivo

    expanded corneal epithelium on amniotic membrane. J Korean

    Med Sci 2006;21:544-549.

    66. Nubile M, Dua HS, Evb-M Lanzini T, Carpineto P, et al. Amniotic

    membrane transplantation for the management of corneal

    epithelial defects: an in vivo confocal microscopic study. Br J

    Ophthalmol 2008;92:54-60.

    67. Dekaris I, Mravicic I, Barisic A, Draca N, Pauk M. Amniotic

    membrane transplantation in the treatment of persistent

    epithelial defect on the corneal graft. Cell Antropol 2010;34

    Suppl 2:15-19.

    68. Muraine M, Descargues G, Franck O, Villeroy F, et al. Amniotic

    membrane graft in ocular surface disease. Prospective studywith 31 cases. J Fr Ophtalmol 2001;24:798-812.

    69. Sangwan VS, Vemuganti GK, Singh S, Balasubramanian D.

    Successful reconstruction of damaged ocular outer surface

    in humans using limbal and conjunctival stem cell culture

    methods. Biosci Rep 2003;23:169-174.

    70. Sangwan VS, Matalia HP, Vemuganti GK, Fatima A, et al.

    Clinical outcome of autologous cultivated limbal epithelium

    transplantation. Indian J Ophthalmol 2006; 54:29-34.

    71. Mermet I, Pottier N, Sainthillier JM, Malugani C, et al. Use of

    amniotic membrane transplantation in the treatment of venous

    leg ulcers. Wound Repair Regen 2007;15: 459-464.

    72. Hasegawa T, Mizoguchi M, Haruna K, Mizuno Y, et al. Amnia for

    intractable skin ulcers with recessive dystrophic epidermolysis

    bullosa: report of three cases. J Dermatol 2007;34:328-332.

    73. Bujang-Safawi E, Halim AS, Khoo TL, Dorai AA. Dried irradia-

    ted human amniotic membrane as a biological dressing for

    facial burns--a 7-year case series. Burns 2010;36: 876-882.

    74. Insausti CL, Alcarz A, Garca-Vizcano EM, Mrowiec A, et

    al. Amniotic membrane induces epithelialization in massive

    posttraumatic wounds. Wound Rep Reg 2010;18:368-377.

    75. Brooke G, Rosstti T, Pelekanos R, Ilic N, et al. Manufacturingof human placenta-derived mesenchymal stem cells for clinical

    trials. British J Haematol 2009;144:571-579.